Research is focused on improving the efficacy and safety of immunotherapies. This includes developing combination therapies that target multiple pathways and identifying biomarkers that can predict which patients are most likely to benefit from treatment. Personalized immunotherapy, tailored to the genetic makeup of an individual's cancer, is also a promising area of research.
